Atomoksetin (Turkish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Atomoksetin" in Turkish language version.

refsWebsite

Global rank Turkish rank

4^th place

11^th place

2^nd place

4^th place

3web.archive.org

1^st place

1^st place

399^th place

156^th place

6^th place

6^th place

1psychiatry.org

low place

4,045^th place

archive.org (Global: 6^th place; Turkish: 6^th place)

"14: Higher Cognitive Function and Behavioral Control". Molecular Neuropharmacology: A Foundation for Clinical Neuroscience. 3. New York: McGraw-Hill Medical. 2015. ISBN 9780071827706.
"Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review". JAMA. 315 (18): 1997-2008. May 2016. doi:10.1001/jama.2016.5453. PMID 27163988.

doi.org (Global: 2^nd place; Turkish: 4^th place)

"A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability". Journal of Child and Adolescent Psychopharmacology. 23 (3): 179-93. April 2013. doi:10.1089/cap.2012.0093. PMC 3696926 . PMID 23560600. KB1 bakım: göster-yazarlar (link)
"Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review". JAMA. 315 (18): 1997-2008. May 2016. doi:10.1001/jama.2016.5453. PMID 27163988.
"Cognitive enhancement as a treatment for drug addictions". Neuropharmacology. 64: 452-63. January 2013. doi:10.1016/j.neuropharm.2012.06.021. PMC 3445733 . PMID 22735770.
"Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation". Pharmaceutical Research. 35 (3): 46. February 2018. doi:10.1007/s11095-017-2323-z. PMID 29411149.
"Clinical pharmacokinetics of atomoxetine". Clinical Pharmacokinetics. 44 (6): 571-90. 2005. doi:10.2165/00003088-200544060-00002. PMID 15910008.

drugs.com (Global: 399^th place; Turkish: 156^th place)

"Atomoxetine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. 4 Nisan 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Mart 2019.
"Atomoxetine Pregnancy and Breastfeeding Warnings". Drugs.com. 22 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Mart 2019.

nih.gov (Global: 4^th place; Turkish: 11^th place)

ncbi.nlm.nih.gov

"A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability". Journal of Child and Adolescent Psychopharmacology. 23 (3): 179-93. April 2013. doi:10.1089/cap.2012.0093. PMC 3696926 . PMID 23560600. KB1 bakım: göster-yazarlar (link)
"Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review". JAMA. 315 (18): 1997-2008. May 2016. doi:10.1001/jama.2016.5453. PMID 27163988.
"Cognitive enhancement as a treatment for drug addictions". Neuropharmacology. 64: 452-63. January 2013. doi:10.1016/j.neuropharm.2012.06.021. PMC 3445733 . PMID 22735770.
"Pharmacological Treatment of Attention Deficit Hyperactivity Disorder During Pregnancy and Lactation". Pharmaceutical Research. 35 (3): 46. February 2018. doi:10.1007/s11095-017-2323-z. PMID 29411149.
"Clinical pharmacokinetics of atomoxetine". Clinical Pharmacokinetics. 44 (6): 571-90. 2005. doi:10.2165/00003088-200544060-00002. PMID 15910008.

psychiatry.org (Global: low place; Turkish: 4,045^th place)

"Parent's Medication Guide: ADHD". American Psychiatric Association. American Psychiatric Association & American Academy of Child and Adolescent Psychiatry (AACAP). June 2013. 2 Şubat 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Ocak 2017. Though not FDA-approved for combined treatment, atomoxetine (Strattera) is sometimes used in conjunction with stimulants as an off-label combination therapy.

web.archive.org (Global: 1^st place; Turkish: 1^st place)

"Atomoxetine Hydrochloride Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. 4 Nisan 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 22 Mart 2019.
"Parent's Medication Guide: ADHD". American Psychiatric Association. American Psychiatric Association & American Academy of Child and Adolescent Psychiatry (AACAP). June 2013. 2 Şubat 2017 tarihinde kaynağından arşivlendi. Erişim tarihi: 1 Ocak 2017. Though not FDA-approved for combined treatment, atomoxetine (Strattera) is sometimes used in conjunction with stimulants as an off-label combination therapy.
"Atomoxetine Pregnancy and Breastfeeding Warnings". Drugs.com. 22 Mart 2019 tarihinde kaynağından arşivlendi. Erişim tarihi: 3 Mart 2019.